CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

BlueCross BlueShield of Kansas

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
A
Index (ASP = 100)
108.1
Vs. acquisition
+5.3%
Brand index
108.1
Biosimilar index
117.4
Contract variability
Low
Drugs observed
847
States
6

Contracts above the typical acquisition benchmark (102.7) on the median drug.

Thin book — treat these figures as indicative, not comparable.

How this payer prices

On this filing, the median drug carries 3 distinct contracted rates across practices, with 96% of billing volume on the single most common rate — an effectively posted price.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.